novel treatment strategies for patients with cml who are intolerant or resistant to available tkis
Published 1 year ago • 86 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
2:54
how novel agents & individualized treatment approaches are improving outcomes in patients with aml
-
1:12
novel treatment strategies for richter’s transformation
-
1:01
advancements in cml: improving treatment-free remission and novel agents
-
2:00
novel treatment strategies in myelofibrosis
-
1:42
novel treatment combinations in aml: what’s to come?
-
5:08
finding novel treatment options for relapsed/progressing aml
-
0:57
novel therapeutic strategies in all
-
1:17
novel agents to improve outcomes for patients with multiple myeloma in the salvage setting
-
2:18
the development of novel treatment modalities: regulations and expectations
-
3:40
how the aml treatment landscape has evolved with the use of novel combination therapies
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:19
updates in cml: recent trials and novel agents
-
1:19
novel combination therapy for cmml: jak inhibitor pacritinib plus azacitidine
-
2:25
novel ai model for personalized risk stratification & treatment in newly diagnosed multiple myeloma
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:34
managing adverse events with novel therapies in lower-risk mds
-
7:55
clinical trials of fixed duration treatments & novel targets in cll
-
1:20
improving patient outcomes in ctcl: clinical collaboration and novel agents